|
|
|||
|
||||
OverviewBiophotonics, Tryptophan and Disease Full Product DetailsAuthor: Laura A. Sordillo (Researcher, Optics/Photonics, Physics and Electrical Engineering Department, The City College of New York, NY, USA) , Peter P. Sordillo (Vice-President and Chief Scientific Officer, SignPath Pharma Inc; Attending Physician in Medical Oncology, Hematology and Internal Medicine, Lenox Hill Hospital, NY, USA)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Weight: 0.570kg ISBN: 9780128227909ISBN 10: 0128227907 Pages: 220 Publication Date: 29 October 2021 Audience: Professional and scholarly , Professional & Vocational Format: Paperback Publisher's Status: Active Availability: Manufactured on demand We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsAuthor InformationLaura A. Sordillo, MS, MPhil, PhD, is a research assistant professor at The Institute for Ultrafast Spectroscopy and Lasers in the physics and electrical engineering departments at The City College of the City University of New York, USA. Her interdisciplinary research involves the development of novel short wavelength infrared techniques for deep tissue imaging of the brain, the application of optical spectroscopy for the assessment of neurodegenerative diseases such as Parkinson’s and Alzheimer’s, as well as of cancer, and the study of ultrafast optical processes in photosynthetic systems. She is the recipient of the Kaylie Entrepreneur Award, the MSKCC-CCNY Graduate Research Award, the 2016-2017 Grove School of Engineering Graduate Fellowship, the 2017-2018 Corning Inc. PhD Fellowship Award and the 2018-2019 Corning Inc. PhD Fellowship Award. She has published more than 60 papers and holds 13 patents. Peter P. Sordillo, M.D., PhD is a physician and cancer researcher whose specialty is the treatment of extremely rare cancers. In addition to his M.D., he holds three graduate degrees in philosophy (causality) (Columbia University), and a graduate degree in physics (NYU). He is Vice-President and Chief Scientific Officer at SignPath Pharma Inc., a biotechnology company; Attending Physician in Medical Oncology, Hematology and Internal Medicine at Lenox Hill Hospital in New York City; and research consultant at The Institute for Ultrafast Spectroscopy and Lasers, Physics Department, The City College of the City University of New York, USA. He has published more than 190 papers and holds 15 patents. Tab Content 6Author Website:Countries AvailableAll regions |
||||